Metabolism of Fructose to Oxalate and Glycolate

Abstract

Much attention has been recently directed at fructose consumption because of its association with obesity and subsequent development of chronic diseases. It was recently reported that an increased fructose intake increases the risk of forming kidney stones. It was postulated that fructose consumption may increase urinary oxalate, a risk factor for calcium oxalate kidney stone disease. However, conflicting results have been obtained in human studies examining the relationship between fructose metabolism and oxalate synthesis. To test whether fructose intake influences urinary excretions impacting kidney stone risk, healthy subjects consumed diets controlled in their contents of fructose, oxalate, calcium, and other nutrients. Subjects consumed diets containing 4, 13, and 21% of calories as fructose in a randomized order. No changes in the excretions of oxalate, calcium, and uric acid were observed. In vitro investigations with cultured liver cells incubated with ¹³C-labeled sugars indicated that neither fructose nor glucose was converted to oxalate by these cells. Fructose metabolism accounted for 12.4±1.6% of the glycolate detected in the culture medium and glucose 6.4±0.9%. Our results suggest that mechanisms for stone risk associated with fructose intake may lie in factors other than those affecting the major stone risk parameters in urine.

nutrition - urolithiasis - HepG2 cells - glyoxal - glucose

References

• 1 Assimos DG, Holmes RP. Role of diet in the therapy of urolithiasis.  Urol Clin North Amer. 2000;  27 255-268
• 2 Taylor EN, Curhan GC. Diet and fluid prescription in stone disease.  Kidney Int. 2006;  70 835-839
• 3 Taylor EN, Fung TT, Curhan GC. DASH-style diet associates with reduced risk for kidney stones.  J Am Soc Nephrol. 2009;  20 2253-2259
• 4 Taylor EN, Curhan GC. Fructose consumption and the risk of kidney stones.  Kidney Int. 2008;  73 207-212
• 5 Milne DB, Nielsen FH. The interaction between dietary fructose and magnesium adversely affects macromineral homeostasis in men.  J Am Coll Nutr. 2000;  19 31-37
• 6 Nguyen NU, Dumoulin G, Henriet M-T, Regnard J. Increase in urinary calcium and oxalate after fructose infusion.  Horm Metab Res. 1995;  27 155-158
• 7 Fox IH, Kelley WN. Studies on the mechanism of fructose-induced hyperuricemia in man.  Metabolism. 1972;  21 713-721
• 8 Abate N, Chandalia M, Cabo-Chan Jr AV, Moe OW, Sakhaee K. The metabolic syndrome and uric acid nephrolithiasis: novel features of renal manifestation of insulin resistance.  Kidney Int. 2004;  65 386-392
• 9 Curhan GC, Taylor EN. 24-h uric acid excretion and the risk of kidney stones.  Kidney Int. 2008;  73 489-496
• 10 Sakhaee K. Recent advances in the pathophysiology of nephrolithiasis.  Kidney Int. 2009;  75 585-595
• 11 Nguyen NU, Dumoulin G, Wolf JP, Berthelay S. Urinary calcium and oxalate excretion during oral fructose or glucose load in man.  Horm Metab Res. 1989;  21 96-99
• 12 Steinmann B, Gitzelmann R, Berghe GVD. Disorders of fructose metabolism. In: Scriver CR, Beaudet AL, Sly WS, Valle D, (eds). The Metabolic and Molecular Bases of Inherited Disease. 8th ed New York: McGraw-Hill; 2001: 1489-1520
• 13 Conyers RAJ, Bais R, Rofe AM. The relation of clinical catastrophes, endogenous oxalate production, and urolithiasis.  Clin Chem. 1990;  36 1717-1730
• 14 Baker PR, Cramer SD, Kennedy M, Assimos DG, Holmes RP. Glycolate and glyoxylate metabolism in HepG2 cells.  Amer J Physiol. 2004;  287 C1359-C1365
• 15 Javitt NB. Hep G2 cells as a resource for metabolic studies: lipoprotein, cholesterol, and bile acids.  FASEB J. 1990;  4 161-168
• 16 Rofe AM, James HM, Bais R, Conyers RAJ. The production of [14C] oxalate during the metabolism of [14C] carbohydrates in isolated rat hepatocytes.  Austral J Exp Biol Med Sci. 1980;  58 103-116
• 17 Holmes RP, Assimos DG. Glyoxylate synthesis, and its modulation and its influence on oxalate synthesis.  J Urol. 1998;  160 1617-1624
• 18 Knight J, Jiang J, Assimos DG, Holmes RP. Hydroxyproline ingestion and urinary oxalate and glycolate excretion.  Kidney Int. 2006;  70 1929-1934
• 19 Holbrook JT, Smith Jr JC, Reiser S. Dietary fructose or starch: effects on copper, zinc, iron, manganese, calcium, and magnesium balances in humans.  Am J Clin Nutr. 1989;  49 1290-1294
• 20 Barngrover DA, Stevens HC, Dills WL. d-Xylulose-1-phosphate: enzymatic assay and production in isolated rat hepatocytes.  Biochem Biophys Res Commun. 1981;  102 75-80
• 21 Kraemer RJ, Deitrich RA. Isolation and charcterization of human liver aldehyde dehydrogenase.  J Biol Chem. 1968;  243 6402-6408
• 22 Thornalley PJ. Glyoxalase I – structure, function and a critical role in the enzymatic defence against glycation.  Biochem Soc Trans. 2003;  31 1343-1348
• 23 Shangari N, Bruce WR, Poon R, O'Brien PJ. Toxicity of glyoxals – role of oxidative stress, metabolic detoxification and thiamine deficiency.  Biochem Soc Trans. 2003;  31 1390-1393
• 24 Chang SH, Garcia J, Melendez JA, Kilberg MS, Agarwal A. Haem oxygenase 1 gene induction by glucose deprivation is mediated by reactive oxygen species via the mitochondrial electron-transport chain.  Biochem J. 2003;  371 877-885
• 25 Emmerson BT. Effect of oral fructose on urate production.  Ann Rheum Dis. 1974;  33 276-280
• 26 Stirpe F, Della Corte E, Bonetti E, Abbondanza A, Abbati A, De Stefano F. Fructose-induced hyperuricaemia.  Lancet. 1970;  2 1310-1311
• 27 Hallfrisch J. Metabolic effects of dietary fructose.  FASEB J. 1990;  4 2652-2660
• 28 Narins RG, Weisberg JS, Myers AR. Effects of carbohydrates on uric acid metabolism.  Metabolism. 1974;  23 455-465
• 29 Evan AP, Lingeman JE, Coe FL, Parks JH, Bledsoe SB, Shao Y, Sommer AJ, Paterson RF, Kuo RL, Grynpas M. Randall's plaque of patients with nephrolithiasis begins in basement membranes of thin loops of Henle.  J Clin Invest. 2003;  111 607-616
• 30 Bergstra AE, Lemmens AG, Beynen AC. Dietary fructose vs. glucose stimulates nephrocalcinogenesis in female rats.  J Nutr. 1993;  123 1320-1327

Correspondence